irst, we thank Marie-Anne Rameix-Welti for the thoughtful comments on our recent paper (1). The M2-1 protein from respiratory syncytial virus (RSV) has for many years been rather enigmatic in allowing researchers to probe its structure and function, with details slow to emerge. In Selvaraj et al. (2), we suggested a model that posited that the requirement of M2-1 in RSV transcription involved binding of an M2-1 tetramer to every viral mRNA transcript via its poly(A) tail, and one option we explored was that this interaction was maintained for the lifetime of the mRNA. This extends the conclusions presented by Rincheval et al. (3). However, we stated that a limitation of this model was that the abundance of M2-1 protein in the cell may be insufficient, governed by the relatively low abundance of M2 mRNAs that encode it. In the helpful letter (1) by Rameix-Welti about our paper (2), calculations are presented to suggest that molar quantities of M2-1 potentially exceed those of total viral mRNAs in the infected cell such that no incongruence exists. We appreciate these efforts to quantify the components of the proposed model which, although hypothetical, do lend support to its feasibility. Of course, we look forward to the time when such quantities can be experimentally determined.
